Search results
US Supreme Court gives pharma companies a chance to thwart terrorism-funding lawsuit
Reuters· 2 days ago, opens new tab to a lawsuit accusing them of illegally helping to fund terrorism that killed or...
I just put £4k into my SIPP. Here’s where I’m going to invest it
Fool.co.uk via Yahoo Finance UK· 5 days agoEdward Sheldon's been contributing to his SIPP to build wealth for retirement. Here’s a look at...
LONDON BRIEFING: Mixed bag for Astra drug; Landsec ups Bluewater stake
Morningstar· 1 day ago"One question that everyone asks is whether last week's good news marked the finale of the Nvidia's surge to the top, and if the past three-day selloff is the beginning of a sharper downside ...
I just put £4k into my SIPP. Here’s where I’m going to invest it
Motley Fool UK· 5 days agoInvesting in a SIPP (Self-Invested Personal Pension) is one of the best ways to build wealth for...
5 Fidelity Mutual Funds to Buy for Long-Term Gains
Zacks via Yahoo Finance UK· 5 days agoInvest in Fidelity mutual funds like FIKGX, FIKAX, FSPCX, FSUTX and FPHAX, which have given impressive returns this year and are expected to perform well...
Britain snubs GSK in favour of US pharma giant for RSV vaccine
Daily Telegraph· 2 days agoThe NHS has turned to US drugs giant Pfizer over its British rival GSK for vaccines against...
The secrets of success with Paul Hudson, CEO of Sanofi, the leader who’s channeling AI to find the...
Fortune via Yahoo Finance UK· 7 days agoSix months later, COVID appeared in China, and a little later, all over the world. In those early...
US FDA approves Roche's drug for a chronic blood disorder
Reuters· 5 days ago, opens new tab drug for a chronic blood disorder, the Swiss drugmaker said. The drug crovalimab,...
Small-Molecule Price Controls Are Short-Sighted
Forbes· 3 days agoThe combination of smoking reduction, increased screening, and pharmaceutical advancements has caused the lung cancer death rate to drop 20% over the...
G1 Therapeutics' breast cancer drug fails in late-stage trial
Reuters· 2 days agoG1 Therapeutics said on Monday its drug for a rare, aggressive form of breast cancer did not meet the main goal of overall survival in a late-stage trial.